Lv21
164 积分 2021-08-24 加入
Ivonescimab versus pembrolizumab for PD-L1-positive non-small cell lung cancer (HARMONi-2): a randomised, double-blind, phase 3 study in China
52分钟前
待确认
Randomized Trial of Two Induction Chemotherapy Regimens in Metastatic Colorectal Cancer: An Updated Analysis
8个月前
已完结
Phase III Trial of Infusional Fluorouracil, Leucovorin, Oxaliplatin, and Irinotecan (FOLFOXIRI) Compared With Infusional Fluorouracil, Leucovorin, and Irinotecan (FOLFIRI) As First-Line Treatment for Metastatic Colorectal Cancer: The Gruppo Oncologico Nord Ovest
8个月前
已完结
Effectiveness of switching from adjuvant tamoxifen to anastrozole in postmenopausal women with hormone-sensitive early-stage breast cancer: a meta-analysis
9个月前
已完结
Molecular classification of hormone receptor-positive HER2-negative breast cancer
9个月前
已完结
[Guidelines for diagnosis and treatment of advanced breast cancer in China (2024 edition)]
10个月前
已完结
The minimum anticipated biological effect level (MABEL) for selection of first human dose in clinical trials with monoclonal antibodies
10个月前
已完结
Application of a MABEL Approach for a T-Cell-Bispecific Monoclonal Antibody: CEA TCB
10个月前
已完结
皖公网安备34019202002308
